CCR5 and neoplasm: Studies suggest that inhibiting the expression of CD47 on tumor cell surfaces or the C-C chemokine receptor type 5 (CCR5) receptor on microglia in GB can increase the ratio of M1/M2-TAMs and improve tumor phagocytosis [91, 92].